TaiwanJ Pharmaceuticals Co., Ltd.(TW:6549)
NT$6.250.00 (0.00%)
TW:6549
TaiwanJ Pharmaceuticals Co., Ltd. financials statements
NT$6.25
At close:0.00 (0.00%)
TaiwanJ Pharmaceuticals Co., Ltd. (6549) Income Statement
TaiwanJ Pharmaceuticals Co., Ltd. Income Statement
Last quarter (Q2 2026), TaiwanJ Pharmaceuticals Co., Ltd.'s total revenue was NT$0.00. In Q2, TaiwanJ Pharmaceuticals Co., Ltd.'s net income was NT$-6.71M. See TaiwanJ Pharmaceuticals Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 0.00 | NT$ 0.00 | NT$ 22.74M | NT$ 15.36M | NT$ 22.06M | |
| NT$ -1.61M | NT$ -1.89M | NT$ 22.74M | NT$ -59.92M | NT$ 22.06M | |
| NT$ 23.61M | NT$ 25.07M | NT$ 29.35M | NT$ 25.72M | NT$ 31.78M | |
| Depreciation and Amortization | NT$ 1.61M | NT$ 1.89M | NT$ 2.01M | NT$ 76.47M | NT$ 1.16M |
| NT$ -23.61M | NT$ -20.44M | NT$ -1.74M | NT$ -15.99M | NT$ -9.15M | |
| NT$ -25.21M | NT$ -26.96M | NT$ -6.61M | NT$ -96.39M | NT$ -9.72M | |
| NT$ 869.00K | NT$ 4.62M | NT$ 2.84M | NT$ 3.93M | NT$ -590.00K | |
| NT$ -24.34M | NT$ -22.34M | NT$ -3.77M | NT$ -92.47M | NT$ -10.31M | |
| NT$ -24.34M | NT$ -22.34M | NT$ -6.05M | NT$ -92.47M | NT$ -12.42M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -0.30 | NT$ -0.29 | NT$ -0.08 | NT$ -1.23 | NT$ -0.16 |
| Diluted EPS | NT$ -0.30 | NT$ -0.29 | NT$ -0.08 | NT$ -1.23 | NT$ -0.16 |
| Weighted Average Shares Outstanding | 80.12M | 76.54M | 75.59M | 75.12M | 75.10M |
| Weighted Average Shares Outstanding (Diluted) | 80.12M | 76.54M | 75.59M | 75.12M | 75.10M |
Currency in TWD

